WeVote

Bill

Bill

HB 3286

DOMESTIC VIOLENCE-RECORDS

104th Regular Session Introduced by Maurice West

HB 3286 lets designated domestic violence fatality reviewers access nonexempt health and HIV records under confidentiality rules to improve investigations and research.

House Floor Amendment No. 1 Rule 19(c) / Re-referred to Rules Committee
0
WeVote Research Nonpartisan
Bill Summary · HB 3286

Summary — HB 3286 (104th General Assembly)

Title: DOMESTIC VIOLENCE‑RECORDS
Primary sponsor: Rep. Maurice A. West, II
Introduced: February 18, 2025
Effective date: Immediate (if enacted)

Purpose / Intent

HB 3286 authorizes limited disclosure and sharing of certain otherwise‑protected health and behavioral‑health records for the purpose of carrying out domestic violence fatality reviews. The bill amends provisions in the Substance Use Disorder Act, the AIDS Confidentiality Act, and the Mental Health and Developmental Disabilities Confidentiality Act to permit access to nonexempt records and HIV‑related information by specified review entities under the Domestic Violence Fatality Review Act.

Key provisions

  • Statutory changes:
    • Amends 20 ILCS 301/30‑5 (Substance Use Disorder Act).
    • Amends 410 ILCS 305/9 (AIDS Confidentiality Act).
    • Amends 740 ILCS 110/7 (Mental Health & Developmental Disabilities Confidentiality Act).
  • Permitted disclosures:
    • Nonexempt records protected under the Substance Use Disorder Act may be disclosed for research activities conducted under the Domestic Violence Fatality Review Act.
    • Staff and any designee of the Illinois Criminal Justice Information Authority (ICJIA), members of the Ad Hoc Statewide Domestic Violence Fatality Review Committee of the ICJIA Board, and regional domestic violence fatality review teams are entitled to receive, inspect, copy, and share HIV‑related information for any person subject to a domestic violence fatality review.
  • Confidentiality and limits:
    • Information disclosed under these provisions remains subject to the confidentiality requirements and protections established by the Domestic Violence Fatality Review Act.
    • The bill limits access to persons/entities participating in or designated under the fatality review process (researchers and review team members), rather than authorizing broad public release.

Who is affected

  • Individuals whose records fall under the Substance Use Disorder Act, AIDS Confidentiality Act, and Mental Health & Developmental Disabilities Confidentiality Act (including decedents and persons involved in fatality reviews).
  • Health care and treatment providers who maintain those records (may receive requests or subpoenas consistent with the new authority).
  • ICJIA staff, the Ad Hoc Statewide Domestic Violence Fatality Review Committee members, and regional fatality review teams (gains statutory access for review/research).
  • Entities conducting domestic violence fatality reviews and related research.

Procedural / timeline status (selected)

  • Filed: 2/18/2025 (first reading 2/18/2025)
  • Referred to Judiciary & Civil Jurisprudence; later assigned to Public Health Committee
  • Public Health Committee: recommended (Do Pass / Short Debate); amendment recommended adopted (committee votes recorded 7–0–0 and 8–0–0 on different actions)
  • House Floor Amendment No. 1 filed 4/8/2025 (deleted a portion of the bill: page 9, line 25 through page 15, line 10)
  • Re‑referred to Rules Committee under Rule 19(c) (most recent status)

Notes / potential impacts

  • The change balances access to sensitive health data for investigative and research purposes related to domestic violence fatalities with statutory confidentiality under the Domestic Violence Fatality Review Act.
  • The bill may facilitate improved multidisciplinary review and research into domestic violence deaths by allowing reviewers and designated researchers to assemble comprehensive records (including HIV‑related and substance use information) that were previously difficult to access.
  • Privacy and compliance protocols in the Domestic Violence Fatality Review Act will govern handling, but providers and patients may have concerns about expanded access to health information even when limited to review contexts.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.